AUBAGIO (teriflunomide): Reviews and patient testimonials


Medication indications

AUBAGIO 14 mg film-coated tablets

AUBAGIO is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (MS).

(please refer to section 5.1 for important information on the population for which efficacy has been established).

Route of administration: Oral
Molecule: teriflunomide

Patients' opinions on AUBAGIO

In brief

General satisfaction level: 8.67/10 Learn more

Treatment's effectiveness: 7.67/10 Learn more

Ease of use: 10.00/10 Learn more

Adherence to prescription: 10.00/10 Learn more

Detected side effects: 3.00/10 Learn more

Improvement in the quality of life: 7.00/10 Learn more

1 = Not at all satisfied
10 = Extremely satisfied

1 = Not at all satisfied
10 = Extremely satisfied

1 = Not at all satisfied
10 = Extremely satisfied

1 = Never
10 = Always

1 = Not at all important
10 = Extremely important

1 = Not at all satisfied
10 = Extremely satisfied

Tips and advice of the community

on 06/10/2023

After years of injecting, copaxone,Rebif and avonex, I wanted to try tablet form so tried tecfidera for 2years and had so many problems with my stomach, I was offered Teriflunomide/Aubagio and never looked back. It’s great 1 tiny tablet a day with little side effects for me.

Your message

on 06/03/2021

I read it was best to take it at night as some people have slight stomach discomfort. I did for the first 2 weeks then it settled down. I've now been on Aubagio for almost 5 years. 

Your message

on 16/04/2019

Effectiveness is a question is really hard to evaluate the effectiveness of MS medication

Your message

Members using this AUBAGIO

Conditions related to this medication

Fact sheet

Multiple sclerosis

See the fact sheet